ciprofloxacin has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blardi, P; Capecchi, PL; Ceccatelli, L; De Lalla, A; Di Perri, T; Pasini, L; Volpi, L | 1 |
1 trial(s) available for ciprofloxacin and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics of neutrophil-associated ciprofloxacin in humans.
Topics: Adult; Aged; Analysis of Variance; Ciprofloxacin; Female; Half-Life; Humans; Luminescent Measurements; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Time Factors | 1995 |